KalVista Pharmaceuticals, Inc. (KALV)

SEC filing

KalVista Pharmaceuticals, Inc.

KALV · CIK 1348911

4 · Feb 19, 2026 · Yea Christopher sold 1,109 shares at $15.00/share ($16,635); exercised options for 1,774 shares

Yea Christopher sold 1,109 shares at $15.00/share ($16,635); exercised options for 1,774 shares

xslF345X05/form4-02202026_120204.xml

xslF345X05/form4-02202026_120204.xmlSEC.gov

Graphics and non-inline formats (not embedded below).